===================== Product Identification =====================
MSDS NAME:(F-ZZ) ANTI-STATIC SUPER FREEZE (NO CFC'S) 1503-12
NIIN:01-386-1967
MSDS Number: CDVYP
=== Responsible Party ===
Company:RAWN CO INC
Address:HWY 53 SOUTH
Box:9
City:SPOONER
State:WI
ZIP:54801
Country:US
Info Phone Num:715-635-8711
Emergency Phone Num:715-635-8102
CAGE:58225
=== Contractor Identification ===
Company:RAWN CO INC
Address:1300 SOUTH RIVER STREET (HWY 53 S)
Box:9
City:SPOONER
State:WI
ZIP:54801
Country:US
Phone:715-635-8711
CAGE:58225
============= Composition/Information on Ingredients =============
Name:METHANE, CHLORODIFLUORO-; (CHLORODIFLUOROMETHANE) (SARA
313) (CERCLA)
CAS:75-45-6
RTECS #:PA6390000
OSHA PEL:1000 PPM
ACGIH TLV:1000 PPM
Ozone Depleting Chemical:2
Name:METHANOL; (METHYL ALCOHOL) (SARA 313) (CERCLA)
CAS:67-56-1
RTECS #:PC1400000
OSHA PEL:200 PPM, S
ACGIH TLV:200PPM/250STEL, S
EPA Rpt Qty:5000 LBS
DOT Rpt Qty:5000 LBS
Name:SUP DAT: MATERNALLY TOX. BASED ON EFTS OF
CHLORODIFLUOROMETHANE IS NOT CONSIDERED A UNIQUE HAZ TO CONCEPTUS &
(ING 4)
RTECS #:9999999ZZ
Name:ING 3: POSES NO CARCIN HAZ WHEN EXPOS ARE BELOW TLV. HUMAN
HLTH EFTS OF OVEREXP BY INHAL, INGEST, SKIN/EYE CONT (ING 5)
RTECS #:9999999ZZ
Name:ING 4: MAY INITIALLY INCL: CNS. HIGHER EXPOS MAY LEAD TO
THESE EFTS: TEMPORARY ALTERATION OF HEART'S ELECTRICITY (ING 6)
RTECS #:9999999ZZ
Name:ING 5: ACTIVITY W/IRREG PULSE, PALPITATIONS/INDAQ
CIRCULATION/FATALITY FROM GROSS OVEREXP. CHLORODIFLUOROMETHANE (ING
7)
RTECS #:9999999ZZ
Name:ING 6: VAPORIZES QUICKLY AT AMBIENT TEMPS; THEREFORE, DATA
TO EVALUATE SKIN PERMEATION HAZ OF THIS CMPD ARE (ING 8)
RTECS #:9999999ZZ
Name:ING 7: INSUFFICIENT. THERE ARE NO RPTS OF HUMAN SENSIT.
CHLOROFLUOROCARBON (CFC'S) MATLS HAVE PRDCED SENSIT OF (ING 9)
RTECS #:9999999ZZ
Name:ING 8: MYOCARDIUM TO EPINEPHRINE IN LAB ANIMALS & COULD
HAVE SIMILAR EFTS IN HUMANS. ADRENOMIMETICS (E.G. (ING 10)
RTECS #:9999999ZZ
Name:ING 9: EPINEPHRINE) MAY BE CONTRAINDICATED EXCEPT FOR
LIFE-SUSTAINING USES IN HUMANS ACUTELY/CHRONICALLY (ING 11)
RTECS #:9999999ZZ
Name:ING 10: EXPOSED TO CHLOROFLUOROCARBONS .
RTECS #:9999999ZZ
Name:FIRST AID PROC: STOM BY INDUCTION OF VOMIT/GASTRIC LAVAGE.
THE USE OF 1-2% SODIUM BICARBONATE IN WATER AS THE (ING 13)
RTECS #:9999999ZZ
Name:ING 12: LAVAGE SOLN HAS BEEN REC AS A COUNTERACTANT TO
METABOLIC ACIDOSIS. CTL SHOCK. MED CONSULT IS ABSOLUTELY (ING 14)
RTECS #:9999999ZZ
Name:ING 13: ESSENTIAL. NOTES TO MD: ING 1: BECAUSE OF POSS
DISTURB OF CARD RHYTHM, CATECHOLAMINE DRUGS SUCH AS (ING 15)
RTECS #:9999999ZZ
Name:ING 14: EPINEPHRINE SHOULD BE USED W/SPECIAL CAUTION ONLY
IN SITUATIONS OF EMER LIFE SUPPORT. ING 2: MED CARE (ING 16
RTECS #:9999999ZZ
Name:ING 15: MUST EMPHASIZE CTL OF ACIDOSIS & USE OF INTRAVENOUS
BICARBONATE HAS BEEN LIFESAVING. EVIDENCE IS GOOD (ING 17)
RTECS #:9999999ZZ
Name:ING 16: THAT TREATMENT OF METHANOL ABSORPTION IS ENHANCED
THRU ADMIN OF ETHANOL, WHICH SHOULD BE GIVEN TO PRDCE (ING 18)
RTECS #:9999999ZZ
Name:ING 17: A BLOOD LEVEL OF AT LEAST 0.1%. ETHANOL DIMINISHES
PRODUCTION OF TOX METABOLITES OF METHANOL. BLOOD (ING 19)
RTECS #:9999999ZZ
Name:ING 18: METHANOL LEVEL OF 50 MG/100 ML IS AN INDICATION FOR
HEMODIALYSIS, WHICH HAS IMPROVED THE PROGNOSIS OF (ING 20)
RTECS #:9999999ZZ
Name:ING 19: METHANOL INTOXICATION.
RTECS #:9999999ZZ
===================== Hazards Identification =====================
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: ING 1: INHAL OF HIGH CONCS OF
VAP IS HARMFUL & MAY CAUSE HEART IRREG, UNCON/DEATH. INTENTIONAL
MISUSE CAN BE FATAL. VAP REDUCES OXYGEN AVAIL FOR BRTHG & IS
HVR/AIR. LIQ CONT CAN CAUSE FROSTBT. ING 2: EYE: IRRIT & REDNESS
WHICH IS TRANSIENT. SKIN: MAY CAUSE DRYNESS, DEFAT, ITCH &/RASH.
(EFFECTS OF OVEREXPOSURE)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ: INHAL: EFTS MAY BE DELAYED. INHAL OF
VAPS MAY PROGRESSIVELY CAUSE MILD INTOX, LETHARGY, ANALGESIA,
NARCOS, LOSS OF CONSCIOUSNESS. INGEST: MAY CAUSE MALAISE,
DISCOMFORT & DEATH UNLESS TREATED PROMPTLY. CHRONIC: ING 1: IN
CHRONIC INHAL STUDIES ING PRDCED SML BUT STATISTICALLY SIGNIFICANT
INCR OF TUMORS(SUP DAT)
Medical Cond Aggravated by Exposure:SKIN DISORDERS AND ALLERGIES, LIVER
DISORDERS, EYE DISEASE.
======================= First Aid Measures =======================
First Aid:INHAL: REMOVE TO FRESH AIR. IF NOT BRTHG, GIVE ARTF RESP. IF
BRTHG IS DFCLT, ADMIN OXYGEN/MOUTH-TO-MOUTH. CALL MD. SEEK MED
ADVICE. SKIN: FLUSH AFFECTED AREA W/SOAP & WATER. TREAT FOR FROSTBT
IF NEC. EYES: IMMED FLUSH W/PLENTY OF WATER FORAT LEAST 15 MIN.
USE FINGERS TO SEPARATE EYELIDS TO ASSURE THAT EYES ARE BEING
IRRIGATED. CALL MD. INGEST: METHANOL MUST BE REMOVED PROMPTLY FROM
THE (ING 12)
===================== Fire Fighting Measures =====================
Flash Point Method:TOC
Flash Point:NONE
Extinguishing Media:AS APPROPRIATE FOR COMBUSTIBLES IN AREA.
Fire Fighting Procedures:WEAR NIOSH APPROVED PRESSURE DEMAND SCBA AND
FULL PROTECTIVE EQUIPMENT . COOL FIRE-EXPOSED CONTAINERS WITH WATER
SPRAY.
Unusual Fire/Explosion Hazard:HIGH TEMPS MAY CAUSE CONTR FAILURE,
THERMODECOMPOSITION OF THIS MATL, PRODUCING HAZARDOUS/TOXIC
BYPRODUCTS. THERMAL DECOMP MAY INCL HCL & PHOSGENE .
================== Accidental Release Measures ==================
Spill Release Procedures:VENTILATE AREA, ESPECIALLY LOW PLACES WHERE
VAPORS MAY COLLECT. USE NIOSH APPROVED SCBA FOR LARGE RELEASES.
THIS MATERIAL RAPIDLY VAPORIZES.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE AWAY FROM HIGH TEMPS, OPEN
FLAMES, INCOMPATIBLES, & OUT OF DIRECT SUNLIGHT AT TEMPS < 120F.
AVOID PRLNG/RPTD BRTHG OF VAPS, EYE & SKIN CONT.
Other Precautions:USE W/ADEQ VENT. NO SMOKING IN AREA OF USE. DO NOT
USE IN THE GENERAL VICINITY OF ARC WELDING, OPEN FLAMES OR HOT
SURFACES. HEAT AND/OR UV RADIATION MAY CAUSE THE FORMATION OF
CHLORIDES, FLUORIDES, OR PHOSGENE .
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NORMAL VENTILATION FOR STANDARD MANUFACTURING
PROCEDURES IS GENERALLY ADEQUATE. IF RECOMMENDED EXPOSURE LIMITS
ARE EXCEEDED, WEAR A NIOSH APPROVED SCBA.
Ventilation:LOCAL EXHAUST SHOULD BE USED WHEN LARGE AMOUNTS RELEASED.
MECHANICAL (GENERAL) SHOULD BE USED IN LOW/CONFINED SPACES.
Protective Gloves:LINED BUTYL GLOVES FOR LIQUID CONTACT.
Eye Protection:ANSI APPRVD CHEM WORKERS GOGGLES .
Other Protective Equipment:ANSI APPRVD EMER EYEWASH & DELUGE SHOWER .
WEAR PROT CLTHG AS NEEDED TO PVNT PRLNG/RPTD SKIN CONT DURING USE.
Work Hygienic Practices:GEN HYGIENIC PRACTICES INCLUDE WASHING HANDS
AFTER USE, BEFORE EATING, DRINKING, OR SMOKING, WITH SOAP AND
WATER.
Supplemental Safety and Health
EFTS OF OVEREXP: IN MALE RATS @ CONCS OF 50,000 PPM (V/V). ING WAS
MUTAGENIC IN BACTERIAL CELL CULTURE. SLIGHT, BUT SIGNIFICANT INCR
IN DEVEL TOXICITY (EYE MALFORMATIONS, DECRD FETAL WTS) HAS BEEN OBS
ERVED IN OFFSPRING OF RATS EXPOSED TO HIGH CONCS (50,000 PPM) OF
CHLORODIFLUOROMETHANE, CONC WHICH WAS ALSO (ING 3)
================== Physical/Chemical Properties ==================
HCC:G3
Boiling Pt:B.P. Text:-41F,-41C
Vapor Pres:7046 @ 77F
Vapor Density:3.03
Spec Gravity:1.194 (H*2O=1)
Evaporation Rate & Reference:>1 (CCL*4=1)
Solubility in Water:NEGLIG (0.30% @ 77F)
Appearance and Odor:CLEAR, LIQUIFIED GAS, SLIGHT ETHEREAL ODOR
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
AVOID CONTACT WITH ALKALI OR ALKALINE EARTH METALS - POWDERED ALUMINUM,
ZINC, BERYLLIUM, AND SO FORTH.
Stability Condition to Avoid:AVOID HIGH TEMPERATURES, OPEN FLAMES.
Hazardous Decomposition Products:PROD CAN BE THERMODECOMPOSED TO PRDCE
HYDROCHLORIC & HYDROFLUORIC ACIDS, POSS CARBONYL HALIDES. PHOSGENE
.
==================== Disposal Considerations ====================
Waste Disposal Methods:CONTACT AUTHORITIES FOR PROPER DISPOSAL
PROCEDURES. COMPLY WITH ALL FEDERAL, STATE OR LOCAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|